vs
Side-by-side financial comparison of MEDIFAST INC (MED) and Velocity Financial, Inc. (VEL). Click either name above to swap in a different company.
MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $51.6M, roughly 1.5× Velocity Financial, Inc.). On growth, Velocity Financial, Inc. posted the faster year-over-year revenue change (32.8% vs -36.9%). Velocity Financial, Inc. produced more free cash flow last quarter ($17.9M vs $-6.6M). Over the past eight quarters, Velocity Financial, Inc.'s revenue compounded faster (32.3% CAGR vs -34.4%).
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
Velocity Financial, Inc. is a U.S.-headquartered real estate finance company that offers specialized mortgage loan solutions primarily for residential investment properties. It partners with independent mortgage brokers nationwide, providing real estate investors with short-term bridge loans and long-term rental property financing options tailored to their operational needs.
MED vs VEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $75.1M | $51.6M |
| Net Profit | — | $34.8M |
| Gross Margin | 69.4% | — |
| Operating Margin | -10.4% | 97.0% |
| Net Margin | — | 67.3% |
| Revenue YoY | -36.9% | 32.8% |
| Net Profit YoY | — | 67.0% |
| EPS (diluted) | $-1.64 | $0.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.1M | $51.6M | ||
| Q3 25 | $89.4M | $49.1M | ||
| Q2 25 | $105.6M | $47.6M | ||
| Q1 25 | $115.7M | $37.5M | ||
| Q4 24 | $119.0M | $38.9M | ||
| Q3 24 | $140.2M | $35.1M | ||
| Q2 24 | $168.6M | $32.4M | ||
| Q1 24 | $174.7M | $29.5M |
| Q4 25 | — | $34.8M | ||
| Q3 25 | $-2.3M | $25.4M | ||
| Q2 25 | $2.5M | $26.0M | ||
| Q1 25 | $-772.0K | $18.9M | ||
| Q4 24 | — | $20.8M | ||
| Q3 24 | $1.1M | $15.8M | ||
| Q2 24 | $-8.2M | $14.8M | ||
| Q1 24 | $8.3M | $17.3M |
| Q4 25 | 69.4% | — | ||
| Q3 25 | 69.5% | — | ||
| Q2 25 | 72.6% | — | ||
| Q1 25 | 72.8% | — | ||
| Q4 24 | 74.1% | — | ||
| Q3 24 | 75.4% | — | ||
| Q2 24 | 73.2% | — | ||
| Q1 24 | 72.8% | — |
| Q4 25 | -10.4% | 97.0% | ||
| Q3 25 | -4.6% | 72.1% | ||
| Q2 25 | -1.0% | 71.3% | ||
| Q1 25 | -1.1% | 71.7% | ||
| Q4 24 | 0.6% | 82.5% | ||
| Q3 24 | 1.5% | 60.6% | ||
| Q2 24 | -4.7% | 61.3% | ||
| Q1 24 | 4.5% | 78.8% |
| Q4 25 | — | 67.3% | ||
| Q3 25 | -2.5% | 51.7% | ||
| Q2 25 | 2.3% | 54.6% | ||
| Q1 25 | -0.7% | 50.4% | ||
| Q4 24 | — | 53.5% | ||
| Q3 24 | 0.8% | 45.1% | ||
| Q2 24 | -4.8% | 45.6% | ||
| Q1 24 | 4.8% | 58.5% |
| Q4 25 | $-1.64 | $0.90 | ||
| Q3 25 | $-0.21 | $0.65 | ||
| Q2 25 | $0.22 | $0.69 | ||
| Q1 25 | $-0.07 | $0.51 | ||
| Q4 24 | $0.08 | $0.56 | ||
| Q3 24 | $0.10 | $0.44 | ||
| Q2 24 | $-0.75 | $0.42 | ||
| Q1 24 | $0.76 | $0.49 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.3M | $92.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $198.9M | $672.5M |
| Total Assets | $248.0M | $7.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.3M | $92.1M | ||
| Q3 25 | $173.5M | $99.0M | ||
| Q2 25 | $162.7M | $79.6M | ||
| Q1 25 | $164.6M | $51.7M | ||
| Q4 24 | $162.3M | $49.9M | ||
| Q3 24 | $170.0M | $44.1M | ||
| Q2 24 | $163.5M | $47.4M | ||
| Q1 24 | $156.4M | $34.8M |
| Q4 25 | $198.9M | $672.5M | ||
| Q3 25 | $214.7M | $634.3M | ||
| Q2 25 | $216.0M | $597.9M | ||
| Q1 25 | $211.0M | $563.2M | ||
| Q4 24 | $210.1M | $516.9M | ||
| Q3 24 | $207.3M | $484.6M | ||
| Q2 24 | $205.3M | $471.3M | ||
| Q1 24 | $211.0M | $452.9M |
| Q4 25 | $248.0M | $7.4B | ||
| Q3 25 | $268.2M | $7.0B | ||
| Q2 25 | $269.3M | $6.5B | ||
| Q1 25 | $280.0M | $6.0B | ||
| Q4 24 | $284.2M | $5.5B | ||
| Q3 24 | $291.2M | $5.2B | ||
| Q2 24 | $293.5M | $4.9B | ||
| Q1 24 | $302.8M | $4.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-5.3M | $18.2M |
| Free Cash FlowOCF − Capex | $-6.6M | $17.9M |
| FCF MarginFCF / Revenue | -8.8% | 34.6% |
| Capex IntensityCapex / Revenue | 1.8% | 0.5% |
| Cash ConversionOCF / Net Profit | — | 0.52× |
| TTM Free Cash FlowTrailing 4 quarters | $1.2M | $40.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.3M | $18.2M | ||
| Q3 25 | $12.1M | $11.5M | ||
| Q2 25 | $-3.4M | $7.7M | ||
| Q1 25 | $3.4M | $3.5M | ||
| Q4 24 | $-4.9M | $37.8M | ||
| Q3 24 | $9.1M | $-17.6M | ||
| Q2 24 | $13.1M | $11.5M | ||
| Q1 24 | $7.3M | $10.6M |
| Q4 25 | $-6.6M | $17.9M | ||
| Q3 25 | $10.8M | $11.4M | ||
| Q2 25 | $-4.8M | $7.6M | ||
| Q1 25 | $1.9M | $3.5M | ||
| Q4 24 | $-7.2M | $37.5M | ||
| Q3 24 | $7.7M | $-17.6M | ||
| Q2 24 | $11.1M | $11.4M | ||
| Q1 24 | $5.4M | $10.5M |
| Q4 25 | -8.8% | 34.6% | ||
| Q3 25 | 12.0% | 23.2% | ||
| Q2 25 | -4.5% | 15.9% | ||
| Q1 25 | 1.6% | 9.2% | ||
| Q4 24 | -6.1% | 96.4% | ||
| Q3 24 | 5.5% | -50.3% | ||
| Q2 24 | 6.6% | 35.1% | ||
| Q1 24 | 3.1% | 35.8% |
| Q4 25 | 1.8% | 0.5% | ||
| Q3 25 | 1.5% | 0.1% | ||
| Q2 25 | 1.3% | 0.2% | ||
| Q1 25 | 1.3% | 0.2% | ||
| Q4 24 | 1.9% | 0.7% | ||
| Q3 24 | 1.0% | 0.2% | ||
| Q2 24 | 1.1% | 0.3% | ||
| Q1 24 | 1.1% | 0.1% |
| Q4 25 | — | 0.52× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | -1.36× | 0.29× | ||
| Q1 25 | — | 0.19× | ||
| Q4 24 | — | 1.81× | ||
| Q3 24 | 8.04× | -1.11× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | 0.88× | 0.61× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MED
Segment breakdown not available.
VEL
| Related Party | $19.3M | 37% |
| Nonrelated Party | $16.9M | 33% |
| Other | $15.4M | 30% |